EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel in patients with non-small-cell lung cancer who had received a platinum-based treatment
Year: 2016
Type: article
Source: Annals of Oncology
Institutions: The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Chinese University of Hong Kong, Prince of Wales Hospital, Kindai University, Wakayama Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Shanghai Chest Hospital, National University Cancer Institute, Singapore, National Taiwan University Hospital, Kyoto University, Sendai Kousei Hospital, National Cancer Center Hospital, Shizuoka Cancer Center, National Cancer Center Hospital East, Miyagi Prefectural Hospital Organization, National Hospital Organization Kyushu Cancer Center, Jilin Province Tumor Hospital, National Cancer Centre Singapore, St. Luke's International Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2586749224
